Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology ; volume:15 ; number:1 ; day:23 ; month:3 ; year:2024 ; pages:1-16 ; date:12.2024
Nature Communications ; 15, Heft 1 (23.3.2024), 1-16, 12.2024
- Urheber
-
Kac, Przemysław R.
González-Ortiz, Fernando
Emeršič, Andreja
Dulewicz, Maciej
Koutarapu, Srinivas
Turton, Michael
An, Yang
Smirnov, Denis
Kulczyńska-Przybik, Agnieszka
Varma, Vijay R.
Ashton, Nicholas J.
Montoliu-Gaya, Laia
Camporesi, Elena
Winkel, Izabela
Paradowski, Bogusław
Moghekar, Abhay
Troncoso, Juan C.
Lashley, Tammaryn
Brinkmalm, Gunnar
Resnick, Susan M.
Mroczko, Barbara
Kvartsberg, Hlin
Gregorič Kramberger, Milica
Hanrieder, Jörg
Čučnik, Saša
Harrison, Peter
Zetterberg, Henrik
Lewczuk, Piotr
Thambisetty, Madhav
Rot, Uroš
Galasko, Douglas
Blennow, Kaj
Karikari, Thomas K.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-46876-7
- URN
-
urn:nbn:de:101:1-2405270912373.851101942216
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kac, Przemysław R.
- González-Ortiz, Fernando
- Emeršič, Andreja
- Dulewicz, Maciej
- Koutarapu, Srinivas
- Turton, Michael
- An, Yang
- Smirnov, Denis
- Kulczyńska-Przybik, Agnieszka
- Varma, Vijay R.
- Ashton, Nicholas J.
- Montoliu-Gaya, Laia
- Camporesi, Elena
- Winkel, Izabela
- Paradowski, Bogusław
- Moghekar, Abhay
- Troncoso, Juan C.
- Lashley, Tammaryn
- Brinkmalm, Gunnar
- Resnick, Susan M.
- Mroczko, Barbara
- Kvartsberg, Hlin
- Gregorič Kramberger, Milica
- Hanrieder, Jörg
- Čučnik, Saša
- Harrison, Peter
- Zetterberg, Henrik
- Lewczuk, Piotr
- Thambisetty, Madhav
- Rot, Uroš
- Galasko, Douglas
- Blennow, Kaj
- Karikari, Thomas K.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias